303 related articles for article (PubMed ID: 27265314)
1. Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance.
Jones MD; Buckton G
Int J Pharm; 2016 Jul; 509(1-2):419-430. PubMed ID: 27265314
[TBL] [Abstract][Full Text] [Related]
2. The cohesive-adhesive balances in dry powder inhaler formulations I: Direct quantification by atomic force microscopy.
Begat P; Morton DA; Staniforth JN; Price R
Pharm Res; 2004 Sep; 21(9):1591-7. PubMed ID: 15497684
[TBL] [Abstract][Full Text] [Related]
3. Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach.
Hooton JC; Jones MD; Price R
J Pharm Sci; 2006 Jun; 95(6):1288-97. PubMed ID: 16637052
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances.
Jones MD; Harris H; Hooton JC; Shur J; King GS; Mathoulin CA; Nichol K; Smith TL; Dawson ML; Ferrie AR; Price R
Eur J Pharm Biopharm; 2008 Jun; 69(2):496-507. PubMed ID: 18191553
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation.
Traini D; Young PM; Jones M; Edge S; Price R
Eur J Pharm Sci; 2006 Feb; 27(2-3):243-51. PubMed ID: 16330191
[TBL] [Abstract][Full Text] [Related]
6. Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation.
Kubavat HA; Shur J; Ruecroft G; Hipkiss D; Price R
Int J Pharm; 2012 Jul; 430(1-2):26-33. PubMed ID: 22449413
[TBL] [Abstract][Full Text] [Related]
7. The influence of crystal habit on the prediction of dry powder inhalation formulation performance using the cohesive-adhesive force balance approach.
Hooton JC; Jones MD; Harris H; Shur J; Price R
Drug Dev Ind Pharm; 2008 Sep; 34(9):974-83. PubMed ID: 18622874
[TBL] [Abstract][Full Text] [Related]
8. Influence of the lactose grade within dry powder formulations of fluticasone propionate and terbutaline sulphate.
Le VN; Bierend H; Robins E; Steckel H; Flament MP
Int J Pharm; 2012 Jan; 422(1-2):75-82. PubMed ID: 22036653
[TBL] [Abstract][Full Text] [Related]
9. The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations.
Price R; Young PM; Edge S; Staniforth JN
Int J Pharm; 2002 Oct; 246(1-2):47-59. PubMed ID: 12270608
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of dry powder inhaler formulations using atomic force microscopy.
Weiss C; McLoughlin P; Cathcart H
Int J Pharm; 2015 Oct; 494(1):393-407. PubMed ID: 26302859
[TBL] [Abstract][Full Text] [Related]
11. Adhesion forces in interactive mixtures for dry powder inhalers--evaluation of a new measuring method.
Lohrmann M; Kappl M; Butt HJ; Urbanetz NA; Lippold BC
Eur J Pharm Biopharm; 2007 Sep; 67(2):579-86. PubMed ID: 17418548
[TBL] [Abstract][Full Text] [Related]
12. The use of inverse gas chromatography for the study of lactose and pharmaceutical materials used in dry powder inhalers.
Jones MD; Young P; Traini D
Adv Drug Deliv Rev; 2012 Mar; 64(3):285-93. PubMed ID: 22265843
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers.
Schiavone H; Palakodaty S; Clark A; York P; Tzannis ST
Int J Pharm; 2004 Aug; 281(1-2):55-66. PubMed ID: 15288343
[TBL] [Abstract][Full Text] [Related]
14. The cohesive-adhesive balances in dry powder inhaler formulations II: influence on fine particle delivery characteristics.
Begat P; Morton DA; Staniforth JN; Price R
Pharm Res; 2004 Oct; 21(10):1826-33. PubMed ID: 15553229
[TBL] [Abstract][Full Text] [Related]
15. The influence of drug loading on formulation structure and aerosol performance in carrier based dry powder inhalers.
Young PM; Wood O; Ooi J; Traini D
Int J Pharm; 2011 Sep; 416(1):129-35. PubMed ID: 21708238
[TBL] [Abstract][Full Text] [Related]
16. Predicting the aerosol performance of dry powder inhalation formulations by interparticulate interaction analysis using inverse gas chromatography.
Tong HH; Shekunov BY; York P; Chow AH
J Pharm Sci; 2006 Jan; 95(1):228-33. PubMed ID: 16315225
[TBL] [Abstract][Full Text] [Related]
17. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
Kaialy W; Ticehurst M; Nokhodchi A
Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
[TBL] [Abstract][Full Text] [Related]
18. Influence of carrier on the performance of dry powder inhalers.
Saint-Lorant G; Leterme P; Gayot A; Flament MP
Int J Pharm; 2007 Apr; 334(1-2):85-91. PubMed ID: 17113733
[TBL] [Abstract][Full Text] [Related]
19. In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers.
Traini D; Young PM; Rogueda P; Price R
Pharm Res; 2007 Jan; 24(1):125-35. PubMed ID: 17103336
[TBL] [Abstract][Full Text] [Related]
20. Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres.
Kaialy W; Hussain T; Alhalaweh A; Nokhodchi A
Pharm Res; 2014 Jan; 31(1):60-76. PubMed ID: 23918220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
